134 related articles for article (PubMed ID: 23897008)
21. Peritoneal Metastasis: A Dilemma and Challenge in the Treatment of Metastatic Colorectal Cancer.
Xia W; Geng Y; Hu W
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067347
[TBL] [Abstract][Full Text] [Related]
22. Impact of Molecular Status on Cytoreductive Surgery for Peritoneal Metastases from Colorectal Cancer.
Zhong Y; Yang K; Qin X; Luo R; Wang H
Clin Colon Rectal Surg; 2023 Nov; 36(6):415-422. PubMed ID: 37795471
[TBL] [Abstract][Full Text] [Related]
23. Multimodal Prehabilitation in Patients Undergoing Complex Colorectal Surgery, Liver Resection, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Pilot Study on Feasibility and Potential Efficacy.
Strijker D; Meijerink WJHJ; van Heusden-Schotalbers LAG; van den Berg MGA; van Asseldonk MJMD; Drager LD; de Wilt JHW; van Laarhoven KJHM; van den Heuvel B
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980756
[TBL] [Abstract][Full Text] [Related]
24. Perioperative Systemic Therapy Versus Cytoreductive Surgery and HIPEC Alone for Resectable Colorectal Peritoneal Metastases: Patient-Reported Outcomes of a Randomized Phase II Trial.
Bakkers C; Rovers KP; Rijken A; Simkens GAAM; Bonhof CS; Nienhuijs SW; Burger JWA; Creemers GJM; Brandt-Kerkhof ARM; Tuynman JB; Aalbers AGJ; Wiezer MJ; de Reuver PR; van Grevenstein WMU; Hemmer PHJ; Punt CJA; Tanis PJ; Mols F; de Hingh IHJT;
Ann Surg Oncol; 2023 May; 30(5):2678-2688. PubMed ID: 36754943
[TBL] [Abstract][Full Text] [Related]
25. PI3K Pathway Alterations in Peritoneal Metastases are Associated with Earlier Recurrence in Patients with Colorectal Cancer Undergoing Optimal Cytoreductive Surgery.
Peerenboom R; Dhiman A; Witmer HDD; Spurr LF; Polite B; Eng OS; Shergill A; Turaga KK
Ann Surg Oncol; 2023 May; 30(5):3114-3122. PubMed ID: 36637640
[TBL] [Abstract][Full Text] [Related]
26. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?
Witmer HDD; Dhiman A; Turaga KK
Cancer; 2023 Feb; 129(4):495-502. PubMed ID: 36527271
[TBL] [Abstract][Full Text] [Related]
27. Impact of cumulative complications on 1-year treatment-related healthcare costs in patients with colorectal peritoneal metastases undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.
van der Zant FA; Kooijman BJL; Hentzen JEKR; Helfrich W; Ploeg EM; van Ginkel RJ; van Leeuwen BL; Been LB; Klaase JM; Hemmer PHJ; van der Hilst CS; Kruijff S
BJS Open; 2022 Sep; 6(5):. PubMed ID: 36218348
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Treatment Algorithms of the Swiss Peritoneal Cancer Group for Peritoneal Cancer of Gastrointestinal Origin.
Adamina M; Warlaumont M; Berger MD; Däster S; Delaloye R; Digklia A; Gloor B; Fritsch R; Koeberle D; Koessler T; Lehmann K; Müller P; Peterli R; Ris F; Steffen T; Weisshaupt CS; Hübner M
Cancers (Basel); 2022 Sep; 14(17):. PubMed ID: 36077810
[TBL] [Abstract][Full Text] [Related]
29. Natural History and Management of Small-Bowel Obstruction in Patients After Cytoreductive Surgery and Intraperitoneal Chemotherapy.
Mor E; Shemla S; Assaf D; Laks S; Benvenisti H; Hazzan D; Shiber M; Shacham-Shmueli E; Margalit O; Halpern N; Boursi B; Beller T; Perelson D; Purim O; Zippel D; Ben-Yaacov A; Nissan A; Adileh M
Ann Surg Oncol; 2022 Dec; 29(13):8566-8579. PubMed ID: 35941342
[TBL] [Abstract][Full Text] [Related]
30. Effect of hyperthermic intraperitoneal chemotherapy in combination with cytoreductive surgery on the prognosis of patients with colorectal cancer peritoneal metastasis: a systematic review and meta-analysis.
Li J; Wang AR; Chen XD; Zhang YX; Pan H; Li SQ
World J Surg Oncol; 2022 Jun; 20(1):200. PubMed ID: 35701802
[TBL] [Abstract][Full Text] [Related]
31. The Impact of Low Skeletal Muscle Mass on Short- and Long-Term Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
Dietz MV; van Kooten JP; van Vugt JLA; Brandt-Kerkhof ARM; Verhoef C; Madsen EVE
Ann Surg Oncol; 2022 Sep; 29(9):5830-5841. PubMed ID: 35650370
[TBL] [Abstract][Full Text] [Related]
32. Unusual site of pseudomyxoma peritonei recurrence after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case report of intraluminal disease manifestation in the small bowel.
Rauwerdink P; Brosens LAA; van Diepen KK; Ghedri ON; Kranenburg O; Boerma D; Witkamp AJ; van Grevenstein HMU
World J Surg Oncol; 2022 May; 20(1):147. PubMed ID: 35538541
[TBL] [Abstract][Full Text] [Related]
33. Survival Outcomes After Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy in Patients with Synchronous Versus Metachronous Onset of Peritoneal Metastases of Colorectal Carcinoma.
Dietz MV; van Kooten JP; Said I; Brandt-Kerkhof ARM; Verhoef C; Bremers AJA; de Wilt JHW; de Reuver PR; Madsen EVE
Ann Surg Oncol; 2022 Oct; 29(11):6566-6576. PubMed ID: 35513588
[TBL] [Abstract][Full Text] [Related]
34. Scrotal Necrosis Following Heated Intra-peritoneal Chemotherapy: Case Report and Review of the Literature.
Fagih SN; Baghdadi RM; Banjer AY; Ismail AA; Addas MA; Shabkah AA; Trabulsi NH
Cureus; 2021 Dec; 13(12):e20638. PubMed ID: 34976544
[TBL] [Abstract][Full Text] [Related]
35. Postoperative bleeding and venous thromboembolism in colorectal cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a systematic review and meta-analysis.
Lundbech M; Krag AE; Iversen LH; Hvas AM
Int J Colorectal Dis; 2022 Jan; 37(1):17-33. PubMed ID: 34626208
[TBL] [Abstract][Full Text] [Related]
36. Quality Standards for Surgery of Colorectal Peritoneal Metastasis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
García-Fadrique A; Estevan Estevan R; Sabater Ortí L
Ann Surg Oncol; 2022 Jan; 29(1):188-202. PubMed ID: 34435297
[TBL] [Abstract][Full Text] [Related]
37. CXCL2-CXCR2 axis mediates αV integrin-dependent peritoneal metastasis of colon cancer cells.
Lepsenyi M; Algethami N; Al-Haidari AA; Algaber A; Syk I; Rahman M; Thorlacius H
Clin Exp Metastasis; 2021 Aug; 38(4):401-410. PubMed ID: 34115261
[TBL] [Abstract][Full Text] [Related]
38. Peritoneal Metastases From Colorectal Cancer: Defining and Addressing the Challenges.
Kranenburg O; van der Speeten K; de Hingh I
Front Oncol; 2021; 11():650098. PubMed ID: 33816304
[TBL] [Abstract][Full Text] [Related]
39. Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases.
Ramanathan R; Choudry H; Jones H; Girgis M; Gooding W; Kalinski P; Bartlett DL
Ann Surg Oncol; 2021 Aug; 28(8):4637-4646. PubMed ID: 33400000
[TBL] [Abstract][Full Text] [Related]
40. The role of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis: a systematic review including evidence from Japan.
Kitai T
Surg Today; 2021 Jul; 51(7):1085-1098. PubMed ID: 33185798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
